Q&A: The ‘urgent need’ for outpatient COVID-19 treatments

Sumary of Q&A: The ‘urgent need’ for outpatient COVID-19 treatments:

  • Against the disease, the authors mentioned that IV monoclonal antibody (mAb) cocktails have received emergency use authorization (EUA) from the FDA for patients with mild to moderate COVID-19..
  • “Easier to administer therapeutics including intramuscular and subcutaneous mAbs and oral antivirals are in clinical trials,”.
  • Regeneron has started advertising it monoclonal antibody cocktail REGEN-COV on television, which is a great idea….

Want to know more click here go to source.

From -
Generic selectors
Exact matches only
Search in title
Search in content

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.